TSVT Stock Overview
2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States.
2seventy bio, Inc. Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||US$14.45|
|52 Week High||US$34.00|
|52 Week Low||US$9.91|
|1 Month Change||-10.91%|
|3 Month Change||-9.74%|
|1 Year Change||-53.31%|
|3 Year Change||n/a|
|5 Year Change||n/a|
|Change since IPO||4.94%|
Recent News & Updates
We're Keeping An Eye On 2seventy bio's (NASDAQ:TSVT) Cash Burn RateOct 04
2seventy Bio: This Spinoff In The CAR-T Space Is AttractiveSep 08
|TSVT||US Biotechs||US Market|
Return vs Industry: TSVT underperformed the US Biotechs industry which returned -11.2% over the past year.
Return vs Market: TSVT underperformed the US Market which returned -21.2% over the past year.
|TSVT Average Weekly Movement||9.6%|
|Biotechs Industry Average Movement||11.1%|
|Market Average Movement||7.4%|
|10% most volatile stocks in US Market||15.5%|
|10% least volatile stocks in US Market||3.3%|
Stable Share Price: TSVT is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 10% a week.
Volatility Over Time: TSVT's weekly volatility (10%) has been stable over the past year.
About the Company
2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a collaboration arrangement with Bristol-Myers Squibb Company.
2seventy bio, Inc. Fundamentals Summary
|TSVT fundamental statistics|
Is TSVT overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|TSVT income statement (TTM)|
|Cost of Revenue||US$278.43m|
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
|Earnings per share (EPS)||-7.70|
|Net Profit Margin||-568.59%|
How did TSVT perform over the long term?See historical performance and comparison